For example, at 5 years follow up time, 50% of BC patients with higher FZD6 expression had disease recurrence compared to only 17% disease recurrence rate for the BC patients with low FZD6 protein expression (Figure 4, p < 0.0001, log-rank). Here, FZD6 is linked to breast cancer.